Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma

BACKGROUND: Despite its toxicity, cisplatin every 3 weeks (q3w) is the standard potentiation of chemo-radiotherapy for head and neck squamous cell carcinoma. This study aimed to determine whether weekly cisplatin (q1w) could be a safe and effective alternative. PATIENTS AND METHODS: Two hundred and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Fayette, Jérôme, Molin, Yann, Lavergne, Emilie, Montbarbon, Xavier, Racadot, Séverine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Ceruse, Philippe, Pommier, Pascal
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4664534/
https://ncbi.nlm.nih.gov/pubmed/26648696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S81488
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi